News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zogenix, Inc. (ZGNX) To Participate In Morgan Stanley (MST) Global Healthcare Conference 2014



9/3/2014 7:35:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO, Sept. 2, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related conditions and central nervous system disorders, today announced that Zogenix management will present at the Morgan Stanley Global Healthcare Conference 2014 in New York, NY on September 10, 2014.

Event: Morgan Stanley Global Healthcare Conference 2014

Date: Wednesday, September 10, 2014

Place: New York City

Time: 10:20 am ET/ 07:20 am PT

The presentation will be webcast live and archived for 30 days on Zogenix' Investor Relations website at ir.zogenix.com. Management will also be available to participate in one-on-one meetings at the conference.

About Zogenix

Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with pain-related conditions and CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.

FPR

CONTACT: Investors Zack Kubow, The Ruth Group 646.536.7020, zkubow@theruthgroup.com

Hey, check out all the research scientist jobs. Post your resume today!

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES